JANSSEN BIOTECH, INC.
HORSHAM, PA

Janssen Biotech, Inc., a prominent player in the pharmaceutical industry, has its headquarters nestled in Horsham, Pennsylvania. As an integral part of Johnson & Johnson's expansive family, it makes significant strides toward tackling some of the most demanding health challenges worldwide across various treatment domains. Established on January 20, 2012, Janssen Biotech is known for its strong legal and corporate foundation in Florida under a filing number F12000000277. As a Foreign for-profit corporation (FORP), it extends its influence beyond local borders. The company stands out by offering a robust platform, JanssenMD™, designed for U.S. healthcare professionals. This site is not just a portal but a reliable hub where scientifically backed information and clinical resources are readily accessible, ensuring that professionals have the insights they need at their fingertips. Communication with interested parties is facilitated through phone lines (800) 526-7736, (908) 218-6095, and (609) 730-2378. Correspondence can be directed to P.O. Box 2317, Horsham, PA 19044. This level of accessibility underscores the company's commitment to transparency and stakeholder engagement. At its core, Janssen Biotech is passionate about using cutting-edge research and development initiatives to address multifaceted medical issues. It consistently upholds stringent standards for ethical practices, ensuring patient safety remains at the forefront of all operations. The leadership team, with the experienced Kevin J. Hamill as Director and vital associates Robert McKeehan and Melissa Miller, steer strategic decisions that propel the company forward. For those seeking comprehensive information about its latest pursuits or specific products, visiting janssenbiotech.com provides a detailed glimpse into the latest developments since their recent annual report in April 2024.